Cow born in Japan after removal, replacement of placental cells
Researchers at Hokkaido University have found that cow embryos from which placenta-forming cells had been removed can regrow those cells, form a placenta and successfully gestate. The scientists recently , which provide insight into the regenerative capacity of mammalian embryos, in the Journal of Biological Chemistry.
All mammalian embryos follow the same blueprint in the first week of development: After being fertilized, a zygote divides into two cells, which quickly become four, eight, then 16 cells that specialize into an inner cell mass and outer cells that are known individually as trophoblasts and collectively as the trophectoderm.
Nanami Kohri, the lead author on the paper, was intrigued by the fact that mouse embryos in which the trophoblasts — which differentiate to form the placenta — had been removed were much less successful in regenerating a placenta than bovine embryos that also had trophoblasts removed.
“Although isolated inner cell masses in both mice and cattle underwent trophectoderm regeneration, they were significantly different in terms of regeneration efficiency, marker protein distribution and expression status of key genes,” he said. “Surprisingly, a calf was successfully delivered after the transfer of the reformed inner cell mass to the surrogate mother, but no descendants were obtained from reformed inner cell masses in mice.”

Kohri and his colleagues at the Laboratory of Animal Breeding and Reproduction previously had isolated bovine inner cell masses from embryos at the early blastocyst stage to find where the genes that give rise to the trophectoderm were being expressed. Other groups had shown that cells positioned at the outer margin of the inner cell mass could be transformed into trophectoderm in mouse embryos.
To understand why the bovine embryos had more success regenerating placental cells than the murine embryos, the researchers at Hokkaido University investigated the expression of the gene SOX17, which creates a protein that regulates cell specialization in development. They found that the expression of SOX17 varied significantly between the two species and was localized to the trophectoderm cells that had been originally absent in murine embryos, which might explain the weaker regenerative capacity.
Kohri and colleagues plan to investigate what drives the differences in embryonic protein expression among mammals as they continue to monitor their calf, which is now 23 months old and healthy.“It has been suggested that the molecular basis of determining cellular divisions and localization in development differs among species,” Kohri said. “In the future, we will have to use our experimental system to evaluate trophectoderm regeneration from the reformed inner cell masses in mice and cattle.”
Enjoy reading ASBMB Today?
Become a member to receive the print edition four times a year and the digital edition monthly.
Learn moreGet the latest from ASBMB Today
Enter your email address, and we鈥檒l send you a weekly email with recent articles, interviews and more.
Latest in Science
Science highlights or most popular articles

RA patient blood reveals joint innerworkings
Researchers in the Netherlands use mass spectrometry to compare the proteome of plasma and synovial fluid in rheumatoid arthritis patients and find a correlation. Read more about this recent paper in Molecular & Cellular Proteomics.

Hope for a cure hangs on research
Amid drastic proposed cuts to biomedical research, rare disease families like Hailey Adkisson鈥檚 fight for survival and hope. Without funding, science can鈥檛 鈥渃atch up鈥 to help the patients who need it most.

Before we鈥檝e lost what we can鈥檛 rebuild: Hope for prion disease
Sonia Vallabh and Eric Minikel, a husband-and-wife team racing to cure prion disease, helped develop ION717, an antisense oligonucleotide treatment now in clinical trials. Their mission is personal 鈥 and just getting started.

Defeating deletions and duplications
Promising therapeutics for chromosome 15 rare neurodevelopmental disorders, including Angelman syndrome, Dup15q syndrome and Prader鈥揥illi syndrome.

Using 'nature鈥檚 mistakes' as a window into Lafora disease
After years of heartbreak, Lafora disease families are fueling glycogen storage research breakthroughs, helping develop therapies that may treat not only Lafora but other related neurological disorders.

Cracking cancer鈥檚 code through functional connections
A machine learning鈥揹erived protein cofunction network is transforming how scientists understand and uncover relationships between proteins in cancer.